|
|
|
|
| LEADER |
00000cam a2200000Mu 4500 |
| 001 |
EBOOKCENTRAL_ocn958385404 |
| 003 |
OCoLC |
| 005 |
20240329122006.0 |
| 006 |
m o d |
| 007 |
cr |n|---||||| |
| 008 |
160917s2015 xx ob 001 0 eng d |
| 040 |
|
|
|a EBLCP
|b eng
|e pn
|c EBLCP
|d YDX
|d OCLCQ
|d WRM
|d MERUC
|d ZCU
|d ICG
|d OCLCO
|d OCLCQ
|d OCLCF
|d TKN
|d DKC
|d AU@
|d OCLCQ
|d UX1
|d OCLCQ
|d COCUF
|d STF
|d LOA
|d USU
|d K6U
|d OCLCO
|d OCLCA
|d OCLCQ
|d OCLCO
|d OCL
|d OCLCQ
|d OCLCO
|
| 066 |
|
|
|c (S
|
| 019 |
|
|
|a 958098254
|a 1055591889
|
| 020 |
|
|
|a 9789386150080
|
| 020 |
|
|
|a 9386150085
|
| 020 |
|
|
|z 9789351526186
|
| 020 |
|
|
|z 9351526186
|
| 035 |
|
|
|a (OCoLC)958385404
|z (OCoLC)958098254
|z (OCoLC)1055591889
|
| 043 |
|
|
|a a-ii---
|
| 050 |
|
4 |
|a RC667
|b .C373 2015
|
| 060 |
|
4 |
|a WG 120
|
| 082 |
0 |
4 |
|a 616.12
|
| 049 |
|
|
|a UAMI
|
| 100 |
1 |
|
|a Chopra, HK.
|
| 245 |
1 |
0 |
|a Cardiological Society of India, Cardiology Update 2014.
|
| 260 |
|
|
|a DL :
|b Jaypee Brothers, Medical Publishers,
|c 2015.
|
| 300 |
|
|
|a 1 online resource (1298 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a Intro -- Prelims -- Section- I -- Chapter-001_Development of Cardiology in India Where are We Today -- Chapter-002_Antiplatelets and Antithrombotics after DES What Next -- Chapter-003_Impact of Kidney Disease on the Outcome and Management of Acute Coronary Syndrome -- Chapter-004_Antiplatelet Drug-resistance in Asian Population -- Chapter-005_Gold or Old Standard New Insights on Aspirin in Cardiovascular Diseases (CVD) Prevention -- Chapter-006_Changing Landscape of Oral Anticoagulants The Last Pieces of the Puzzle -- Chapter-007_Top Ten Most Promising New and Future Therapies in Cardiology Status Report 2014 -- Chapter-008_A Cardiologists Viewpoint on Gliptins The New Star on the Horizon of Diabetes -- Chapter-009_Statins as Primary Preventive Strategy -- Chapter-010_Management of Atherogenic Dyslipidemia Triad Indian Perspective -- Chapter-011_Lipid Management Beyond Statins Targeting HDL and TG Challenges 2014 -- Chapter-012_Management of Hypertriglyceridemia and Cardiovascular Risk Reduction -- Chapter-013_Beta-blockers and Coronary Artery Disease Status 2014 -- Chapter-014_Statin Guidelines Controversies to Consensus (What to Follow in 2014) -- Chapter-015_ARBs and CVD Protection New Dimension 2014 -- Chapter-016_Amiodarone and Cardiovascular Disease Protection Clinical Implications 2014 -- Chapter-017_Gaps and Challenges in Antiplatelet Therapy Indian Perspective -- Chapter-018_Triple Antiplatelet Therapy in Acute Coronary Syndrome in 2014 -- Chapter-019_Drug-Drug Interactions in Cardiology -- Chapter-020_Pharmacoinvasive Strategy in the Treatment of STEMI -- Chapter-021_Post-PTCA and Post-CABG Care What is New in 2014 -- Chapter-022_Acute Coronary Syndrome Management Strategies Recent Advances 2014 -- Section- II -- Chapter-023_Genetics and Coronary Artery Disease-Challenges -- Chapter-024_Coronary Artery Disease Risk Factor Stratification.
|
| 505 |
8 |
|
|a Chapter-025_Vitamin D and Cardiovascular Disease -- Chapter-026_Tobacco and Heart -- Chapter-027_Stress and Heart -- Chapter-028_Role of Psychosocial Factors and Relaxation Techniques in the Etiology and Prevention of Cardiovascular Diseases -- Chapter-029_Trans Fat and Cardiovascular Disease -- Chapter-030_Homocysteine and Coronary Artery Disease -- Chapter-031_State-of-the-art Review on Metabolic Syndrome, Diabetes, and Cardiovascular Disease -- Chapter-032_Vulnerable Plaque in a Vulnerable Patient How to Manage -- Chapter-033_Microvascular CAD Management Issues 2014 -- Chapter-034_Hormone Replacement Therapy and Heart -- Chapter-035_Lifestyle and Coronary Artery Disease -- Chapter-036_Using Health Behavior Change Theory to Guide Health Promotion to Prevent Noncommunicable Diseases in India -- Section- III -- Chapter-037_Nutrition and Heart -- Chapter-038_CoQ10 and CVD Risk Reduction 2014 -- Chapter-039_CoQ10 in CHF and CAD Potentials and Challenges Ahead -- Chapter-040_Edible Oils in Cardiovascular Disease Protection -- Chapter-041_Management of Obesity By Optimizing Nutrition -- Section- IV -- Chapter-042_Coronary Artery Disease and Biomarkers -- Chapter-043_Electrocardiogram Pitfalls in Diagnosis and Artifacts -- Chapter-044_Echocardiography Beginning, Present, and FutureEchocardiography Beginning, Present, and Future -- Chapter-045_Stress Echocardiography and Coronary Artery Disease -- Chapter-046_Stress Myocardial Perfusion Imaging -- Chapter-047_LV Diastolic Function Evaluation What is Practical -- Chapter-048_Echocardiographic Evaluation in Elderly What is New -- Chapter-049_Myocardial Contrast Echocardiography Usefulness and Pitfalls -- Chapter-050_Echocardiography and Post-MI Complications -- Chapter-051_Three-dimensional Echocardiography Is it Superior to Two-dimensional Echocardiography for Valvular Heart Disease.
|
| 505 |
8 |
|
|a Chapter-052_Strain and Strain Rate Imaging Clinical Implications 2014 -- Chapter-053_Need of Cardiac Evaluation in Obesity -- Section- V -- Chapter-054_Management of Acute Myocardial Infarction in 2014 -- Chapter-055_Thrombolysis in Acute Myocardial Infarction Which Agent is the Right Choice -- Chapter-056_Primary Angioplasty in 2014 -- Chapter-057_Thrombus Aspiration During Primary Percutaneous Coronary Angioplasty -- Chapter-058_Cardiogenic Shock in Acute Myocardial Infarction -- Chapter-059_Post-MI Risk Stratification and Cardiac Rehabilitation -- Chapter-060_Revascularization in Acute Myocardial Infarction Patients 24 Hours after Thrombolysis -- Chapter-061_Thrombolytic Therapy in STEMI Interventions -- Section- VI -- Chapter-062_Chronic Total Occlusion (CTO) Strategies and Wiring Techniques -- Chapter-063_Chronic Total Occlusion Management Strategies 2014 -- Chapter-064_Radial Angioplasty Tips and Tricks -- Chapter-065_Guidelines for PCI 2014 Training for Percutaneous Coronary Intervention Appropriateness, Indications and Directions -- Chapter-066_Complex Coronary Angioplasty Procedure Tips and Tricks -- Chapter-067_Drug-eluting Stents Differing Platforms and Outcome -- Chapter-068_Role of Rotational Atherectomy in Percutaneous Coronary Interventions -- Chapter-069_Can We Predict Stent Thrombosis and So Prevent It -- Chapter-070_Biovascular Scaffolds New Dimension 2014 -- Chapter-071_Indigenous Stents Examining the Clinical Data on New Technologies -- Chapter-072_Hybrid Coronary Revascularization An Integrated Best of Both Worlds Approach to Revascularization -- Chapter-073_Management of Coronary Stent Restenosis New Dimensions -- Chapter-074_Saphenous Vein Grafts Intervention Challenges 2014 -- Section- VII -- Chapter-075_Carotid Evaluation How to Do, 2014 -- Chapter-076_Carotid Intervention Current Status and Future Direction.
|
| 505 |
8 |
|
|a Chapter-077_Aortic Evaluation and Interventions Status 2014 -- Chapter-078_Peripheral Vascular Evaluation and Intervention -- Chapter-079_Chronic Lower Limb Ischemia Management Strategies -- Chapter-080_Erectile Dysfunction and Coronary Artery Disease -- Section- VIII -- Chapter-081_Biomarkers in Heart Failure Newer Horizon -- Chapter-082_Echo and Diastolic Heart Failure -- Chapter-083_BNP Evaluation Guidelines in CHF -- Chapter-084_Anemia in Chronic Heart Failure -- Chapter-085_When to Revascularize in Heart Failure -- Chapter-086_Acute Decompensated Heart Failure -- Chapter-087_Managing Comorbidities in Heart Failure -- Chapter-088_CHF and CKD-Double Jeopardy How to Manage -- Chapter-089_Heart Failure Management in Women Is it Different -- Chapter-090_Left Ventricular Assist Devices New Frontiers 2014 -- Section- IX -- Chapter-091_Approach to a Newly Diagnosed Hypertensive Patient -- Chapter-092_Ambulatory BP Monitoring Is It Really Essential -- Chapter-093_Cardiovascular Risk in Hypertension How to Manage It -- Chapter-094_Role of Echocardiography in Hypertension -- Chapter-095_Nonpharmacological Management of Hypertension 2014 -- Chapter-096_Resistant Hypertension Clinical Evaluation and Management -- Chapter-097_Indian Practical Guidelines for Management of Hypertension -- Chapter-098_Choosing the Right Drug for Your Hypertensive Patient A Look at Comorbidities -- Chapter-099_Renal Denervation Present Status and Future Direction -- Chapter-100_Recent Advances in Hypertension Management for Cardiovascular Disease Prevention -- Chapter-101_Hypertension Paradoxes -- Chapter-102_Hypertension Management Strategy in Renal Artery Stenosis -- Chapter-103_Central Aortic Blood Pressure as a Prognostic Marker in Hypertension -- Section- X -- Chapter-104_TAVR Present Status and Challenges Ahead.
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
| 650 |
|
0 |
|a Cardiology.
|
| 650 |
|
0 |
|a Cardiovascular system
|x Diseases.
|
| 650 |
|
2 |
|a Cardiovascular Diseases
|
| 651 |
|
2 |
|a India
|
| 650 |
|
2 |
|a Cardiology
|
| 650 |
|
6 |
|a Cardiologie.
|
| 650 |
|
6 |
|a Appareil cardiovasculaire
|x Maladies.
|
| 650 |
|
7 |
|a Cardiovascular system
|x Diseases
|2 fast
|
| 650 |
|
7 |
|a Cardiology
|2 fast
|
| 700 |
1 |
|
|a Ramakrishnan, S.
|
| 700 |
1 |
|
|a Pancholia, AK.
|
| 776 |
0 |
8 |
|i Print version:
|a Chopra, HK.
|t Cardiological Society of India, Cardiology Update 2014.
|d DL : Jaypee Brothers, Medical Publishers, ©2015
|z 9789351526186
|
| 856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=4660881
|z Texto completo
|
| 880 |
8 |
|
|6 505-00/(S
|a Chapter-105_Percutaneous Mitral Valvuloplasty Tips and Tricks -- Chapter-106_Rheumatic Heart Disease Epidemiology and Management -- Chapter-107_Echocardiography in Rheumatic Heart Disease -- Chapter-108_Percutaneous Valve Repair Replacement Status 2014 -- Chapter-109_Prosthetic Valve Thrombosis Management Strategies -- Chapter-110_Echo Navigation A Glimpse into the Future -- Chapter-111_Complex Issues in Aortic Valve Diseases -- Section- XI -- Chapter-112_Management of Dilated Cardiomyopathy -- Chapter-113_Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy Current Status -- Chapter-114_Genetic Evaluation in Hypertrophic Cardiomyopathy -- Chapter-115_Restrictive Cardiomyopathy Management Strategies -- Chapter-116_Peripartum Cardiomyopathy -- Chapter-117_Stress Cardiomyopathy -- Section- XII -- Chapter-118_High Sensitivity C-reactive Protein The Most Powerful Predictor of Occult Cardiovascular Disease in Patients of Metabolic Syndrome A Hospital-based Study -- Chapter-119_Heart Disease and Exercise in Cold Weather -- Chapter-120_Exercise and CVD Protection in Metabolic Syndrome -- Chapter-121_Obesity, CAD and Heart Failure A Triple Jeopardy -- Chapter-122_Review of First Approved Dual PPAR αγ Agonist, Saroglitazar A Cardiologists Perspective -- Section- XIII -- Chapter-123_CAD Preventive Strategies in Diabetes Mellitus -- Chapter-124_Management of Coronary Artery Disease in Diabetes Mellitus-Is It Different -- Chapter-125_CAD and CKD A Double Jeopardy Management Strategies -- Section- XIV -- Chapter-126_Hypertension in Pregnancy Management Strategies -- Chapter-127_Management of Valvular Heart Disease in Pregnancy -- Chapter-128_Pregnancy and Pulmonary Embolism How to Manage -- Section- XV -- Chapter-129_Management of Takayasus Arteritis -- Chapter-130_Uremic Cardiomyopathy Is it an Entity -- Section- XVI.
|
| 938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL4660881
|
| 938 |
|
|
|a YBP Library Services
|b YANK
|n 13152441
|
| 994 |
|
|
|a 92
|b IZTAP
|
